All news from Venereology

AIDS

HIV Remission: Achieved In Second Patient

A second person has experienced sustained remission from HIV-1 after ceasing treatment; reports a paper led by researchers at UCL and Imperial College London. The case report, published in Nature and carried out with partners at the University of Cambridge and the University of Oxford, comes ten years after the first such case, known as…

AIDS

One Step Closer To A HIV Cure

Scientists associated with the University of the Witwatersrand; Johannesburg are part of an international team that today published research suggesting a cure for HIV. Scientists found no rebound of HIV in two patients who stopped taking their HIV medication after they received stem cell transplants for a hematological [blood] disease. Both patients underwent stem cell…

AIDS

HIV PrEP: Behavior Change Don't Justify

Preexposure prophylaxis (PrEP) for HIV is an antiretroviral pill that is over 90% effective in preventing HIV acquisition when taken; as prescribed. A new Perspective, published in the issue of the New England Journal of Medicine; examines clinicians’ concerns and biases toward prescribing PrEP and suggests strategies to mitigate those biases. The Perspective, “Risk Compensation and…

AIDS

Tracking HIV's Ever-evolving Genome

Every county in the United States tracks HIV cases, sequencing the virus’ genome to see if it is resistant to current medications and looking for trends. More recently, local health departments and the Centers for Disease Control and Prevention (CDC) have begun using those HIV genetic sequences; to trace the virus’ transmission history. They can…

AIDS

Potent HIV Antibody: Improvement Of Vaccine Design

The human immunodeficiency viruses (HIV) are two species of Lentivirus that causes HIV infection; and over time acquired immunodeficiency syndrome (AIDS). However, AIDS is a condition in humans; in which progressive failure of the immune system allows life-threatening opportunistic infections; and cancers to thrive. So, without treatment; average survival time after infection with HIV; is estimated to be…

AIDS

HIV Patients: Anti-retroviral Drug Regimens Provide 'Lazarus Effect'

Treatment of the HIV/AIDS epidemic has seen remarkable advancements with the advent of the latest anti-retroviral drug therapy; and powerful tools to test for drug resistance; making the infection almost “undetectable” in patients who strictly comply with their medication therapy; a just-published perspective article by a clinical team at the University of Arizona College of…

AIDS

Anti-cancer Immunotherapy To Fight HIV

Researchers at the University of Montreal Hospital Research Centre (CRCHUM) have shown that immunotherapy treatments against cancer could reduce the amount of virus that persists in people on triple therapy. In a study published in the journal Nature Communications, they show, in the cells of people living with HIV, how these therapies reveal the virus —…

AIDS

HIV Drug Treat Alzheimer's, Age-associated Disorders

A new study found that an HIV drug significantly reduces age-related inflammation and other signs of aging in mice. “This holds promise for treating age-associated disorders including Alzheimer’s,” said John Sedivy, professor of medical science and biology at Brown University. “And not just Alzheimer’s but many other diseases: Type 2 diabetes, Parkinson’s, macular degeneration, arthritis,…

AIDS

CD4 Protects Chimpanzees From AIDS-like Viruses

Medical researchers have found that the CD4 surface protein, which is used by HIV and SIV as the receptor to enter immune cells, is highly variable among wild chimpanzees. Understanding how these viruses are transmitted within and between species may reveal clues for novel vaccine strategies in humans. Beatrice H. Hahn and her colleagues have…

AIDS protein

Immune Response: HIV-1 Protein Suppresses

Scientists have revealed how a protein produced by HIV-1 plays a broader role in suppressing the immune system’s response to infection than previously thought. Their findings could help inform more effective treatment strategies for HIV, including those aimed at activating the dormant virus in patients before subsequently eliminating it. The study, published in eLife, comes from…

HIV

New Clues To Control HIV: Study Finds

The immune system is the body’s best defense in fighting diseases like HIV and cancer. Now, an international team of researchers is harnessing the immune system; to reveal new clues that may help in efforts to produce an HIV vaccine. SFU professor Mark Brockman and co-authors from the University of KwaZulu-Natal in South Africa have…

AIDS

Black HIV Patients Interviewed For Partner Services

Identifying persons with human immunodeficiency virus (HIV) infection who are unaware of their infection status, linking them to HIV care, and reducing racial/ethnic disparities are important national HIV prevention goals. HIV infection isproportionately affect Blacks/African Americans in the United States. Although blacks represent 13% of the U.S. population, in 2017, 44% of diagnoses of HIV…